Efficacy of monoclonal antibody anti CD20 in extranodal minimal residual disease eradication

被引：0
|
作者：
Petrilli, M. P.
Cinieri, S.
Giordano, G.
Ruggiero, T.
Cavotta, S.
Capussela, E.
Ferrandina, C.
Gasbarrino, C.
Fraticelli, V.
Monaco, M.
Storti, S.
机构：
[1] Univ Cattolica Sacro Cuore, Ctr Ric & Formaz Alta Tecnol Sci Biomed, Unit Operat Oncoematol, Sede Campobasso, Italy
[2] Univ OORR, UO Ematol Azienda Mista Osped, Foggia, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [41] Development and Characterization of a New Antipeptide Monoclonal Antibody Directed to Human CD20 Antigen
    Habibi-Anbouhi, Mahdi
    Azadmanesh, Kayhan
    Behdani, Mahdi
    Hajizadeh-Saffar, Ensiyeh
    Vahabpour, Rouhollah
    Shokrgozar, Mohammad Ali
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2015, 30 (07) : 310 - 316
  • [42] The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders
    Musto, Pellegrino
    D'Auria, Fiorella
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (05) : 551 - 557
  • [43] Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity
    Winiarska, Magdalena
    Nowis, Dominika
    Bil, Jacek
    Glodkowska-Mrowka, Eliza
    Muchowicz, Angelika
    Wanczyk, Malgorzata
    Bojarczuk, Kamil
    Dwojak, Michal
    Firczuk, Malgorzata
    Wilczek, Ewa
    Wachowska, Malgorzata
    Roszczenko, Katarzyna
    Miaczynska, Marta
    Chlebowska, Justyna
    Basak, Grzegorz Wladyslaw
    Golab, Jakub
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (38) : 31983 - 31993
  • [44] ADULT STILL'S DISEASE REFRACTORY TO TNFα AND ANTI ANTI CD20
    Yucra, D.
    Paris, V
    Parra, M.
    Beron, A.
    Curti, A.
    Dubinsky, D.
    Nasswetter, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S91 - S92
  • [45] Anti-CD20 monoclonal antibody/thalidomideMyeloproliferative disorder in an elderly patient (first report with anti-CD20 monoclonal antibody): case report
    Reactions Weekly, 2001, 855 (1) : 7 - 7
  • [46] Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus
    Rossi, Edmund A.
    Chang, Chien-Hsing
    Goldenberg, David M.
    PLOS ONE, 2014, 9 (05):
  • [47] Changes in Immunoglobulin in Patients with Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies
    Vollmer, Brandi
    Bourassa, Timber
    Dao, Vi
    Sillau, Stefan
    Alvarez, Enrique
    Nair, Kavita
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 340 - 340
  • [48] Unique molecular recognition of CD20 by the type II CD20 antibody GA101
    Niederfellner, G. J.
    Lammens, A.
    Georges, G. J.
    Schwaiger, M.
    Franke, A.
    Wiechmann, K.
    Moessner, E.
    Umana, P.
    Hopfner, K. P.
    Klein, C.
    EJC SUPPLEMENTS, 2010, 8 (07): : 75 - 76
  • [49] CD20 ligation using rituximab (anti-CD20 monoclonal antibody) inhibits growth of EBV infected B cells from a patient with PTLD.
    Chen, LJ
    Nepomuceno, RR
    Beatty, PR
    Krams, SM
    Esquivel, CO
    Martinez, OM
    TRANSPLANTATION, 2000, 69 (08) : S331 - S331
  • [50] Prenyl Transferases Are Involved in the Regulation of CD20 Levels and Influence Anti-CD20 Monoclonal Antibody-Mediated Activation of Complement-Dependent Cytotoxicity
    Nowis, Dominika
    Winiarska, Magdalena
    Bil, Jacek
    Muchowicz, Angelika
    Wanczyk, Malgorzata
    Glodkowska-Mrowka, Eliza
    Bojarczuk, Kamil
    Firczuk, Malgorzata
    Wilczek, Ewa
    Wachowska, Malgorzata
    Chlebowska, Justyna
    Dwojak, Michal
    Miaczynska, Marta
    Stoklosa, Tomasz
    Golab, Jakub
    BLOOD, 2011, 118 (21) : 1590 - 1590
12345